Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.

Zouboulis CC, Hansen H, Caposiena Caro RD, Damiani G, Delorme I, Pascual JC, Reguiai Z, Trigoni A, Vilarrasa E, Alfageme Roldán F.

Open source

DOI
10.1159/000503606
Published
2019-10-18
Container
Dermatology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000503606,
  title = {Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.},
  author = {Zouboulis CC and  Hansen H and  Caposiena Caro RD and  Damiani G and  Delorme I and  Pascual JC and  Reguiai Z and  Trigoni A and  Vilarrasa E and  Alfageme Roldán F.},
  year = {2020},
  journal = {Dermatology},
  doi = {10.1159/000503606},
  url = {https://doi.org/10.1159/000503606}
}

RIS

TY  - JOUR
TI  - Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.
AU  - Zouboulis CC
AU  -  Hansen H
AU  -  Caposiena Caro RD
AU  -  Damiani G
AU  -  Delorme I
AU  -  Pascual JC
AU  -  Reguiai Z
AU  -  Trigoni A
AU  -  Vilarrasa E
AU  -  Alfageme Roldán F.
PY  - 2020
JO  - Dermatology
DO  - 10.1159/000503606
UR  - https://doi.org/10.1159/000503606
ER  - 

APA

CC, Z., H, H., RD, C. C., G, D., I, D., JC, P., Z, R., A, T., E, V., & F., A. R. (2020). Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.. Dermatology. https://doi.org/10.1159/000503606

Source records